Alzheimer's caregivers rate dissolving memantine tablets vs. standard pills
NCT ID NCT07417670
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether caregivers prefer a fast-dissolving memantine tablet (Sinolvir®) or the standard tablet (Eutebrol®) for people with moderate to severe Alzheimer's disease. About 105 patients took one form daily for two months, and their primary caregivers filled out a satisfaction questionnaire. The goal was to see which option caregivers found more convenient and acceptable, while also tracking any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Ángeles del Pedregal
Mexico City, 10700, Mexico
-
Private Geriatrics Practice
Guadalajara, Jalisco, 44670, Mexico
-
Private Practice
Saltillo, Coahuila, 44670, Mexico
-
Private Practice
Monterrey, Nuevo León, 64520, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking thousands of dementia cases reshape how we care for patients?
- PET scans probe link between brain inflammation and Alzheimer's damage
- Can sound waves soothe Dementia's emotional turmoil?
- Can a Low-Dose immune calmer slow Alzheimer's decline?
- A stumble before memory slips? study tests if falls predict Alzheimer's
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?